Abstract PD-042: RATIONALISING BLOOD PRODUCT USE IN PAEDIATRIC PATIENTS UNDERGOING EXTRACORPOREAL MEMBRANE OXYGENATED THERAPY. (June 2018) - Branescu, I.; Timms, D.; Narayanan, A.; Gala-Peralta, S.; Jackson, T.; Burmester, M.; Macrae, D.; Desai, A.